Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta by Cabral Wayne A, Chang Weizhong, Barnes Aileen M, Weis MaryAnn, Scott Melissa A, Leikin Sergey, Makareeva Elena, Kuznetsova Natalia V, Rosenbaum Kenneth N, Tifft Cynthia J, Bulas Dorothy I, Kozma Chahira, Smith Peter A, Eyre David R, Marini Joan C in Nature genetics (2007).

[PMID: 17277775] PubMed


A recessive form of severe osteogenesis imperfecta that is not caused by mutations in type I collagen has long been suspected. Mutations in human CRTAP (cartilage-associated protein) causing recessive bone disease have been reported. CRTAP forms a complex with cyclophilin B and prolyl 3-hydroxylase 1, which is encoded by LEPRE1 and hydroxylates one residue in type I collagen, alpha1(I)Pro986. We present the first five cases of a new recessive bone disorder resulting from null LEPRE1 alleles; its phenotype overlaps with lethal/severe osteogenesis imperfecta but has distinctive features. Furthermore, a mutant allele from West Africa, also found in African Americans, occurs in four of five cases. All proband LEPRE1 mutations led to premature termination codons and minimal mRNA and protein. Proband collagen had minimal 3-hydroxylation of alpha1(I)Pro986 but excess lysyl hydroxylation and glycosylation along the collagen helix. Proband collagen secretion was moderately delayed, but total collagen secretion was increased. Prolyl 3-hydroxylase 1 is therefore crucial for bone development and collagen helix formation.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.